$ACCD News
Last published 8mo ago
- 8mo agoACCDDefining Wellness Centers Names Bill Morrison Chief Financial OfficerPR NewswireDefining Wellness Centers (www.definingwellness.com) today announced that veteran healthcare executive Bill Morrison has joined the organization as...
- 1y agoACCDTDOCDigital health startup Transcarent takes Accolade private in $621 million dealCNBCTranscarent CEO Glen Tullman previously led Livongo, which was purchased by Teladoc in a 2020 agreement that valued the company at $18.5 billion.
- 1y agoACCDTranscarent Completes Merger With AccoladeBusiness WireCreating the Most Comprehensive Health and Care Platform for Employers and Health Plans Serving 20 Million Members & 1,700 Employer and Health Plan Clients Today Transcarent announced the successful completion of
- 1y agoACCDAccolade Stockholders Approve Merger Between Accolade and TranscarentGlobeNewswireSEATTLE, March 27, 2025 (GLOBE NEWSWIRE) -- Accolade (NASDAQ:ACCD) announced that Accolade stockholders voted to approve the merger with Transcarent at the Accolade special meeting of stockholders (the "Special
- 1y agoACCDAccolade Welcomes Oshi Health to Trusted Partner EcosystemPR NewswireAccolade, Inc. (Nasdaq: ACCD) has partnered with Oshi Health, a leading virtual clinic specializing in gastrointestinal (GI) conditions that delivers ...
- 1y agoACCDTranscarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger TransactionGlobeNewswireSAN FRANCISCO and SEATTLE, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and primary care, today
- 1y agoACCDAccolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer OfferingPR NewswireToday, Accolade, Inc. (NASDAQ: ACCD) announced that its direct-to-consumer virtual healthcare offering, PlushCare, is now accepting Medicare Part B,...
- 1y agoMDGLKMPHBMYPFE+6Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the marketCNBCThe FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will take Accolade private.
- 1y agoACCDTranscarent To Acquire AccoladeGlobeNewswireCombined company creates industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment Transcarent's Generative AI WayFinding and care experiences combined with
- 1y agoACCDTranscarent To Acquire AccoladeBusiness WireCombined company creates an industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment Transcarent's Generative AI WayFinding and care experiences combined
- 1y agoBSXACCDFDA Roundup: December 17, 2024FDA Press ReleasesToday, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA posted four warning letters to companies for introducing unapproved GLP-1s, including semaglutide, tirzepatide and/or retatrutide products into interstate commerce. The letters were sent to: Xcel Peptides SwisschemsSummit Research Prime PeptidesThe agency also sent a warni ...
- 1y agoACCDAccolade to Announce Fiscal Third Quarter 2025 Financial ResultsGlobeNewswireSEATTLE, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced that it will release fiscal third quarter 2025 financial results on Thursday, January 9, 2024 after the market closes. In
- 1y agoACCDAccolade To Present at Upcoming Investor ConferencesGlobeNewswireSEATTLE, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced that it will be presenting at the following upcoming investor events. A webcast will be available at ir.accolade.com and a replay
- 2y agoACCDAccolade Welcomes Renalogic to Trusted Partner EcosystemPR NewswireAccolade, Inc. (Nasdaq: ACCD) today announced that Renalogic, the recognized industry leader that manages the human and financial costs of chronic...
- 2y agoACCDAccolade, Inc. (ACCD) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoACCDAccolade Announces Results for Fiscal Second Quarter 2025GlobeNewswireSEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced financial results for the fiscal second quarter ended August 31, 2024. "As we enter the second half of fiscal year 2025, we are
- 2y agoACCDAccolade to Announce Fiscal Second Quarter 2025 Financial ResultsGlobeNewswireSEATTLE, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced that it will release fiscal second quarter 2025 financial results on Tuesday, October 8, 2024 before market open. In conjunction,
- 2y agoACCDAccolade To Present at Morgan Stanley 22nd Annual Global Healthcare ConferenceGlobeNewswireSEATTLE, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced that it will be presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Thursday, September 5 at
- 2y agoACCDFirst-of-its-kind Healthcare Innovation Provides Synchronized, Customized Whole-Health StrategiesPR NewswireCeleste Health Solutions (Celeste), a new company that will focus on merging the power of data insights, technology and personalized health...
- 2y agoACCDAccolade To Present at Canaccord Genuity 44th Annual Growth Conference & Private Company ShowcaseGlobeNewswireSEATTLE, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced that it will be presenting at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase in Boston on
- 2y agoACCDAccolade, Inc. (ACCD) Q1 2025 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoACCDAccolade Announces Results for Fiscal First Quarter 2025GlobeNewswireSEATTLE, June 27, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024. "Accolade's physician-led advocacy approach to solving the
- 2y agoACCDAccolade to Announce Fiscal First Quarter 2025 Financial ResultsGlobeNewswireSEATTLE, June 12, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced that it will release fiscal first quarter 2025 financial results on Thursday, June 27, 2024, after the market closes. In
- 2y agoACCDAccolade To Present at William Blair Growth Stock ConferenceGlobeNewswireSEATTLE, May 29, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced that it will be presenting at the William Blair Growth Stock Conference in Chicago on Tuesday, June 4 at 2:00 pm CT. A webcast
- 2y agoACCDAccolade Welcomes Noom to Trusted Partner EcosystemPR NewswireAccolade, Inc. (Nasdaq: ACCD) announced today that Noom has joined Accolade's Trusted Partner Ecosystem to provide customers with a comprehensive...
- 2y agoACCDAccolade, Inc. (ACCD) Q4 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoACCDAccolade Announces Results for Fiscal Fourth Quarter and Full Year 2024GlobeNewswireSEATTLE, April 25, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 29, 2024. "Accolade has built a rare healthcare
- 2y agoACCDAccolade to Announce Fiscal Fourth Quarter 2024 Financial ResultsGlobeNewswireSEATTLE, April 03, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced that it will release fiscal fourth quarter 2024 financial results on Thursday, April 25, 2024, after the market closes. In
- 2y agoACCDAccolade Wins 2024 Artificial Intelligence Excellence AwardPR NewswireAccolade, Inc. (Nasdaq: ACCD) today announced it has been named a winner of the Business Intelligence Group's Artificial Intelligence Excellence...
- 2y agoACCDAccolade Promotes Kelsi McDonald Harris to Chief People OfficerPR NewswireAccolade, Inc. (Nasdaq: ACCD) announced today the promotion of Kelsi McDonald Harris as Chief People Officer and Senior Vice President. "Transforming ...
- 2y agoACCDAccolade To Present at Upcoming Investor ConferencesGlobeNewswireSEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced that it will be presenting at the following upcoming investor conferences: Raymond James 45th Annual Institutional Investors
- 2y agoACCDAccolade Welcomes Brightline to Trusted Partner EcosystemPR NewswireAccolade, Inc. (Nasdaq: ACCD) announced today that Brightline, a comprehensive pediatric behavioral health solution built for children, teens, their...
- 2y agoACCDAccolade Welcomes Kindbody to Trusted Partner EcosystemPR NewswireAccolade, Inc. (Nasdaq: ACCD) today announced that Kindbody, a technology-driven fertility clinic network and family-building benefits provider for...
- 2y agoACCDAccolade, Inc. (ACCD) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoACCDAccolade Announces Results for Fiscal Third Quarter 2024GlobeNewswireSEATTLE, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced financial results for the fiscal third quarter ended November 30, 2023. "As we head into the new year, Accolade continues to
- 2y agoACCDAccolade To Present at Upcoming Investor ConferencesGlobeNewswireSEATTLE, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced that it will be presenting at the following upcoming investor conferences: 42nd Annual J.P. Morgan Healthcare Conference in San
- 2y agoACCDAccolade to Announce Fiscal Third Quarter 2024 Financial ResultsGlobeNewswireSEATTLE, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced that it will release fiscal third quarter 2024 financial results on Monday, January 8, 2024, after the market closes. In
- 2y agoACCDAccolade To Present at Piper Sandler 35th Annual Healthcare ConferenceGlobeNewswireSEATTLE, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Piper Sandler 35th Annual Healthcare
- 2y agoACCDAccolade Announces Repurchase of $76.5 Million of 0.50% Convertible Senior Notes Due 2026GlobeNewswireSEATTLE, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced that it has entered into separate, privately negotiated transactions with certain holders of its outstanding 0.50% Convertible
- 3y agoACCDAccolade To Present at Stephens Annual Investment ConferenceGlobeNewswireSEATTLE, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Stephen Annual Investment Conference in
- 3y agoACCDAccolade Named to 2023 Deloitte Technology Fast 500™PR NewswireAccolade today announced it has been named to the Deloitte Technology Fast 500™, a ranking of the fastest-growing technology, media,...
- 3y agoACCDGLP-1 Coverage in Employer Plans Could Nearly Double in 2024PR NewswireEmployer survey: 25% of employers currently offer coverage and most experience positive outcomes; 4 in 10 consider it an immediate concern and intend to offer in 2024; while 21% of HR decision-makers are unaware of GLP-1
- 3y agoACCDAccolade Announces Results for Fiscal Second Quarter 2024GlobeNewswireSEATTLE, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced financial results for the fiscal second quarter ended August 31, 2023. "We are halfway through the 2024 fiscal year and the
- 3y agoACCDAccolade to Announce Fiscal Second Quarter 2024 Financial ResultsGlobeNewswireSEATTLE, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal second quarter 2024 financial results on
- 3y agoACCDAccolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare ExperiencePR NewswireWelcomes Dr. Connie Hwang as chief medical officer, creates roles of chief health officer and chief nursing officer SEATTLE, Sept. 18, 2023 /PRNewswire/ -- Accolade (NASDAQ:ACCD) announced the expansion of its care
- 3y agoACCDAccolade To Present at Upcoming Investor ConferencesGlobeNewswireSEATTLE, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the following upcoming investor
- 3y agoACCDAccolade Announces Results for Fiscal First Quarter 2024GlobeNewswireAccolade exceeds guidance for fiscal first quarter and raises guidance for fiscal year 2024 SEATTLE, June 29, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD) today announced financial results for the fiscal
- 3y agoACCDAccolade to Announce Fiscal First Quarter 2024 Financial ResultsGlobeNewswireSEATTLE, June 13, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ:ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal first quarter 2024 financial results on
- 3y agoACCDEquip Partnership Adds Eating Disorder Support to Accolade's Trusted Partner EcosystemPR NewswireAccolade and Equip offer employers purpose-built integrations to address barriers to eating disorder treatment. SEATTLE, June 7, 2023 /PRNewswire/ -- Accolade, Inc. (NASDAQ:ACCD), the company that provides millions of
- 3y agoACCDReport: Employees are Overwhelmed, Delaying Care at High RatesPR NewswireNew health trends report explores causes of stress and offers solutions, including virtual care expansion and enhanced health equity. SEATTLE, June 5, 2023 /PRNewswire/ -- Accolade (NASDAQ:ACCD), the company that